Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma
American Journal of Hematology - United States
doi 10.1002/ajh.25278
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 9, 2018
Authors
Publisher
Wiley